EGFR-Mutant Non-Small-Cell Lung Cancer at Surgical Stages: What Is the Place for Tyrosine Kinase Inhibitors?

por Cansouline, Xavier, Lipan, Béatrice, Sizaret, Damien, Tallet, Anne, Vandier, Christophe, Carmier, Delphine, Legras, Antoine
Publicado 2022